BridgeMD
New treatment option for Alzheimer Disease
Official title Nature-based Virtual Reality Intervention for Depression in Alzheimer's Disease
ClinicalTrials.gov ID: NCT06732128
What this study is testing
- What it's testing
- Behavioural and psychological symptoms of dementia (BPSD), such as depression affect up to 90% patients with dementia. Non-pharmacological treatment of BPSD, can be difficult to access, require caregiver support, travel, and often have long waiting lists.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 and older
You may be able to join if
- Clinical diagnosis of mild to early-moderate stage AD (including mixed dementia with AD) using the Diagnostic and Statistical Manual of Mental...
- Age of 50 years or older
- Medical stability to participate in the trial
- Patient Health Questionnaire score 5-14
- Investigator judgement on whether the participant is comfortable with technology
You likely can't join if
- Unstable medical or psychiatric condition, including substance use based on an investigator opinion
- Visual or hearing impairments that would impair participation
- Patient Health Questionnaire score 15-27 and/or score of 1 or 2 in section E question 1 of the Cornell Scale for Depression in Dementia
- Any other reason, which will make the study participation intolerable for the participant in the opinion of the study investigator
See the full eligibility criteria
- Clinical diagnosis of mild to early-moderate stage AD (including mixed dementia with AD) using the Diagnostic and Statistical Manual of Mental Disorders, 5th Ed. Criteria
- Age of 50 years or older
- Medical stability to participate in the trial
- Patient Health Questionnaire score 5-14
- Investigator judgement on whether the participant is comfortable with technology
- Access to WiFi and a smart device for connecting on WebEx and downloading the Fitbit and Muse applications
- Have someone available to be present during all sessions
- Unstable medical or psychiatric condition, including substance use based on an investigator opinion
- Visual or hearing impairments that would impair participation
- Patient Health Questionnaire score 15-27 and/or score of 1 or 2 in section E question 1 of the Cornell Scale for Depression in Dementia
- Any other reason, which will make the study participation intolerable for the participant in the opinion of the study investigator
The study team makes the final eligibility decision.
Where it's taking place
- Toronto, Ontario, Canada
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Toronto, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.